日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor

CPI-1612 的发现:一种高效、选择性强且口服生物利用度高的 EP300/CBP 组蛋白乙酰转移酶抑制剂

Wilson, Jonathan E; Patel, Gaurav; Patel, Chirag; Brucelle, Francois; Huhn, Annissa; Gardberg, Anna S; Poy, Florence; Cantone, Nico; Bommi-Reddy, Archana; Sims, Robert J 3rd; Cummings, Richard T; Levell, Julian R

Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors

苯乙烯基环丙胺类LSD1抑制剂的设计与合成

Gehling, Victor S; McGrath, John P; Duplessis, Martin; Khanna, Avinash; Brucelle, Francois; Vaswani, Rishi G; Côté, Alexandre; Stuckey, Jacob; Watson, Venita; Cummings, Richard T; Balasubramanian, Srividya; Iyer, Priyadarshini; Sawant, Priyanka; Good, Andrew C; Albrecht, Brian K; Harmange, Jean-Christophe; Audia, James E; Bellon, Steven F; Trojer, Patrick; Levell, Julian R